2 Matching Annotations
  1. Last 7 days
    1. Case reportA 5-year-old male, known to be a carrier of a VHL variant leading to a p.V170G substitution, presented to the Urology clinic in 2009 for pheohchromocytoma screening. His previous medical history was unremarkable.The boy’s mother was the index case in this VHL family. She was diagnosed incidentally with bilateral pheochromocytoma at the age of 23 years and underwent bilateral adrenalectomy. Following this, the mother had genetic screening for VHL. This also prompted screening of her kindred. Over time, DNA sequencing from blood of consenting family members condirmed the presence of a VHL variant in seven family members (three generations, all from maternal side) (Fig. 1). The seven members were found to carry the variant p.V170G (c.509.T>G), a mutation of exon 3 of the VHL tumor suppressor gene that leads to substitution of a surface amino acid valine with glycine at the 170 position in the resulting VHL protein. The c.509.T>G mutation in VHL is pathogenic (see acknowledgements) and has been previously associated with pheochromcytomas, ccRCC, retinal hemangioblastomas, paragangliomas and pancreatic neuroendocrine tumors [3,4,5].Fig. 1Pedigree of a family severely affected by a missense mutation of the VHL gene (p.V170G). The members with the variant identified are presented in color. The first brother (our patient) described in this case report is indicated by an arrowFull size imageUpon commencing follow-up, our patient was clinically asymptomatic. His blood pressure was within normal limits. The baseline neurologic evaluation was normal, as well his ophthalmology and audiology evaluations. His baseline abdominal ultrasound (US) did not reveal any abnormal masses and his baseline urinary and plasma catecholamine levels were normal. As per suggested protocols he underwent annual screening with US and plasma or urinary catecholamines (Table 1).Nine months after his last annual visit, at the age of 7 years, the patient presented with a 3-month history of flushing, night sweats, heat intolerance and intermittent headaches. His systolic blood pressure was elevated at 160 mmHg. His baseline plasma norepinephrine level was increased to 27,233 pmol/L (normal range: 1180–3550 pmol/L), a 15-fold increase compared to the level measured 9 months prior. An abdominal US followed by magnetic resonance imaging (MRI) showed a left suprarenal mass measuring 4.8 cm in its greater dimension. The metaiodobenzylguanidine (MIBG) scan was negative, probably due to the fact that the boy had already started treatment with alpha-adrenergic blockers to control his hypertension. As a definitive treatment, the patient underwent total adrenalectomy (the mass was too large for partial resection) using a retroperitoneoscopic approach [6]. Pathology revealed a pheochromocytoma that measured 4.2 cm in its greater dimension and weighed 35 g.Thereafter, a first accelerated protocol was developed, which consisted of visits every 6 months, with annual US alternating with annual plasma catecholamines. At the age of 10 years, a new solid mass was observed on routine US in the right adrenal gland measuring 2 cm. MRI and MIBG confirmed the finding. His plasma catecholamines level increased to 20,947 pmol/L, a sevenfold increase compared to the level measured 1 year prior. During that period of time he complained of fatigue but denied any other symptoms associated with pheochromocytoma. Mild hypertension was observed. Right retroperitoneoscopic adrenalectomy was delayed 3 months due to family reasons. Due to its central location next to the adrenal vein, a partial adrenalectomy was not feasible. Pathological evaluation confirmed a pheochromocytoma measuring 4 cm in its greater dimension. Six years after his second surgery he remains asymptomatic with normal blood pressure and no clinical evidence for recurrence of pheochromocytoma. He remains on fludrocortisone and hydrocortisone as hormone replacement therapy.

      PatientID: N/A (case report - older son of index case)

      KindredID: 1

      Case: M, 16Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: The patient's mother was the index case in this VHL family, as she was diagnosed with bilateral pheochromocytoma at age 23 and underwent bilateral adrenalectomy. Genetic screening revealed the VHL variant, which prompted screening of family members. DNA sequencing from blood of consenting family members confirmed the presence of the VHL variant in seven family members (three generations) (see figure 1 for familial pedigree). This included the mother (index case), the patient, his brother, maternal grandmother, uncle and two cousins. The brother, who was 3 years younger, presented with an adrenal mass, which required total adrenalectomy and remains well 2.5 years later. The uncle developed hemangioblastoma, multiple bilateral renal cell carcinomas, bilateral pheochromocytomas, and succumbed to his disease at age 45. The uncle's two daughters both had the mutation. One of which was found to have pheochromocytoma at age 15 due to routine screening. The other 8 year old daughter has not had any manifestations. No phenotype was noted for the grandmother.

      CasePresentingHPOs: HP:0006748 (adrenal pheochromocytoma)

      CaseHPOFreeText: The 5Y0M patient presented to a urology clinic in 2009 for pheohchromocytoma screening due to a known VHL heterozygous V170G(c.509.T>G) missense variant in the VHL gene, despite unremarkable medical history. The patient remained asymptomaticuntil nine months after his annual visit at age 7, where he was admitted to the hospital due to 3-months of flushing, night sweats, heat intolerance and headaches. An abdominal ultrasound and MRI showed a left suprarenal mass. A total adrenalectomy was performed since the mass was too big for partial adrenalectomy. Pathology confirmed a left pheochromocytoma. At age 10, routine ultrasound revealed a new mass in the right adrenal gland measuring 2 cm, confirmed by MRI. Right adrenalectomy was delayed 3 months, but pathology confirmed a pheochromocytoma. Six years after his second surgery he is asymptomatic with no clinical evidence for recurrence. He remains on fludrocortisone and hydrocortisone as hormone replacement therapy.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.V170G (c.509T>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351756196, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.509T%3EG

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; tranversion

      CivicName: V170G (c.509T>G)

      MultipleGeneVariants: N/A

  2. Nov 2026
    1. 214Y4Y20NNNYNC.340G.AExon 1p.Gly114SerMissense

      PatientID: 2

      KindredID: 1

      Case: M, 20Y0M, Brazilian (Latino/Admixed American)

      DiseaseAssertion: VHL

      FamilyInfo: Also belonging to family 1, patients 1 and 3 had VHL diagnoses and phenotypes. Their relation is not clear.

      CasePresentingHPOs: HP:0006748, HP:0002666; HP:0030405; HP:0010797 (adrenal pheochromocytoma, pheochromocytoma, pancreatic endocrine tumor, hemangioblastoma)

      CaseHPOFreeText: The patient developed PPGL at 4Y of age, and a PNET at 20Y: the 4-year-old boy with VHL disease with a history of sudoresis, headache, and abdominal pain. During evaluation, he was diagnosed with hypertension. An abdominal CT scan revealed a 5-cm heterogenous mass in the right adrenal and normal left adrenal glands. This patient underwent a right nodulectomy to preserve normal adrenal tissue. Anatomopathological diagnosis confirmed PHEO. 3 years later was a bilateral recurrence (4-cm right and 1.5-cm left nodules). The patient underwent a right-side adrenalectomy and a left-side nodulectomy. He remained without hormone replacement. After 13 years from the second surgery, the boy presented with a left-side recurrence (1.3-cm nodule) and elevated plasmatic normetanephrine levels; he underwent left-side adrenalectomy.

      CaseNotHPOs: HP:0005584; HP:0009711; HP:0001737; HP:0000107 (renal cell carcinoma, retinal capillary hemangioma, pancreatic cyst, renal cyst)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.G114S (c.340G>A)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 583094 https://www.ncbi.nlm.nih.gov/clinvar/variation/583094/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: G114S (c.340G>A)

      MultipleGeneVariants: N/A